New vaccine for Breast cancer effective in lab
A research conducted at Wayne State University has found a breast cancer vaccine that completely eliminates cancers that are resistant to current anti-HER2 therapy – without any toxicity in mice. The study suggests the vaccine could treat women with HER2-positive breast cancer. The vaccine has the potential to eliminate the need to depend on use of current therapies. It consists of naked DNA – genes that produce the HER2 receptor along with an immune stimulant.
- Study shows newer cancer drug more effective in postmenopausal women
- Cervical Cancer Vaccine Gets Lukewarm Reception Despite MN Approval
- ImmunoCellular’s Cancer Vaccine Demonstrates Immune Response Against Brain Cancer
- Biocon launches Abraxane in UAE
